297 related articles for article (PubMed ID: 21975014)
1. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-λ1 pathway.
Wang D; Fang L; Liu L; Zhong H; Chen Q; Luo R; Liu X; Zhang Z; Chen H; Xiao S
Mol Immunol; 2011 Oct; 49(1-2):407-12. PubMed ID: 21975014
[TBL] [Abstract][Full Text] [Related]
2. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.
Wang D; Fang L; Li K; Zhong H; Fan J; Ouyang C; Zhang H; Duan E; Luo R; Zhang Z; Liu X; Chen H; Xiao S
J Virol; 2012 Sep; 86(17):9311-22. PubMed ID: 22718831
[TBL] [Abstract][Full Text] [Related]
3. Expression of exogenous IFN-alpha by bypassing the translation block protects cells against FMDV infection.
Xiong Y; Lin M; Yuan B; Yuan T; Zheng C
Antiviral Res; 2009 Oct; 84(1):60-6. PubMed ID: 19607862
[TBL] [Abstract][Full Text] [Related]
4. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels.
Wang D; Fang L; Luo R; Ye R; Fang Y; Xie L; Chen H; Xiao S
Biochem Biophys Res Commun; 2010 Aug; 399(1):72-8. PubMed ID: 20638368
[TBL] [Abstract][Full Text] [Related]
5. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen.
Grubman MJ; Moraes MP; Diaz-San Segundo F; Pena L; de los Santos T
FEMS Immunol Med Microbiol; 2008 Jun; 53(1):8-17. PubMed ID: 18400012
[TBL] [Abstract][Full Text] [Related]
6. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
[TBL] [Abstract][Full Text] [Related]
7. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus.
Kim SM; Kim SK; Park JH; Lee KN; Ko YJ; Lee HS; Seo MG; Shin YK; Kim B
Antiviral Res; 2014 Apr; 104():52-8. PubMed ID: 24485895
[TBL] [Abstract][Full Text] [Related]
8. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus L
Sui C; Jiang D; Wu X; Liu S; Li F; Pan L; Cong X; Li J; Yoo D; Rock DL; Miller LC; Lee C; Du Y; Qi J
J Virol; 2021 Jul; 95(15):e0036121. PubMed ID: 33980594
[TBL] [Abstract][Full Text] [Related]
10. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions.
Summerfield A; Guzylack-Piriou L; Harwood L; McCullough KC
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):205-10. PubMed ID: 19026453
[TBL] [Abstract][Full Text] [Related]
11. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
[TBL] [Abstract][Full Text] [Related]
13. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells.
Zhang ZD; Hutching G; Kitching P; Alexandersen S
Arch Virol; 2002 Nov; 147(11):2157-67. PubMed ID: 12417950
[TBL] [Abstract][Full Text] [Related]
14. Expression of porcine Mx1 with FMDV IRES enhances the antiviral activity against foot-and-mouth disease virus in PK-15 cells.
Yuan B; Fang H; Shen C; Zheng C
Arch Virol; 2015 Aug; 160(8):1989-99. PubMed ID: 26047650
[TBL] [Abstract][Full Text] [Related]
15. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
[TBL] [Abstract][Full Text] [Related]
16. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ
J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a chimeric foot-and-mouth disease virus bearing a bovine rhinitis B virus leader proteinase.
Uddowla S; Pacheco JM; Larson C; Bishop E; Rodriguez LL; Rai DK; Arzt J; Rieder E
Virology; 2013 Dec; 447(1-2):172-80. PubMed ID: 24210112
[TBL] [Abstract][Full Text] [Related]
19. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine.
Díaz-San Segundo F; Salguero FJ; de Avila A; de Marco MM; Sánchez-Martín MA; Sevilla N
J Virol; 2006 Mar; 80(5):2369-79. PubMed ID: 16474143
[TBL] [Abstract][Full Text] [Related]
20. Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation.
Visser LJ; Medina GN; Rabouw HH; de Groot RJ; Langereis MA; de Los Santos T; van Kuppeveld FJM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
